Canadian Cardiovascular Society
Canadian Perspectives

Canadian Perspectives on the ACC 2023 – Session 1

Starts: May 3, 2023 8:00 p.m. EDT

Ends: May 3, 2023 9:00 p.m. EDT

Royal College MOC Credits: 1 Opens in a new window

Learning Objectives

  • Review new data relevant to clinical practice (Leader, Collaborator, Professional, Expert, Communicator, Scholar)
  • Discuss the latest clinical trial data from ACC 2023 and apply it to daily practice ((Leader, Collaborator, Professional, Expert, Communicator, Scholar)


  • Moderated by: Dr. Anil Gupta
  • Dr. Nathan Brunner
  • Dr. Paul Dorian


8:00 – 8:05 PM EDT – Introduction to the program and faculty
8:05 – 8:35 PM EDT – Trial summaries
8:35 – 9:00 PM EDT – Panel discussion on the applicability and implications of the trials

Trial Topics

  • Vigorous Exercise in Individuals With Hypertrophic Cardiomyopathy (HCM): Primary Results Of The Prospective, MultinationalLifestyle And Exercise In HCM (LIVE-HCM) Study
  • Return-to-play for Elite Level Athletes With Sudden Cardiac Death Predisposing Genetic Heart Diseases
  • Lifelong Endurance Exercise and its Relationship With Coronary Atherosclerosis
  • The STELLAR Phase III Trial: A Study of Sotatercept In Combination With Background Therapy for the Treatment of Pulmonary Arterial Hypertension Opens in a new window

Back to top